BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25623232)

  • 1. ZBP-89 reduces histone deacetylase 3 by degrading IkappaB in the presence of Pin1.
    Ye CG; Liu L; Chen GG; Tang XL; He Z; He ML; Lai PB
    J Transl Med; 2015 Jan; 13():23. PubMed ID: 25623232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
    Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
    Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
    Ye CG; Chen GG; Ho RLK; Merchant JL; He ML; Lai PBS
    Biochim Biophys Acta; 2013 Dec; 1833(12):2970-2979. PubMed ID: 23954442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
    Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
    Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
    Kong X; Xu P; Cai WJ; Wang HG; Li BB; Huang GL; He ZW; Chen G; Ye CG
    BMC Cancer; 2018 Apr; 18(1):419. PubMed ID: 29653560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cudraxanthone H Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via NF-κB and PIN1 Pathways.
    Lee HJ; Jue SS; Kang SK; Bae WJ; Kim YC; Kim EC
    Am J Chin Med; 2015; 43(7):1439-52. PubMed ID: 26477796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells.
    To AK; Chen GG; Chan UP; Ye C; Yun JP; Ho RL; Tessier A; Merchant JL; Lai PB
    Biochim Biophys Acta; 2011 Jan; 1813(1):222-30. PubMed ID: 20850481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolyl isomerase Pin1 functions in mitotic chromosome condensation.
    Xu YX; Manley JL
    Mol Cell; 2007 Apr; 26(2):287-300. PubMed ID: 17466629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1 associates with and induces translocation of CRTC2 to the cytosol, thereby suppressing cAMP-responsive element transcriptional activity.
    Nakatsu Y; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Horike N; Yoneda M; Ohno H; Tsuchiya Y; Kamata H; Tahara H; Isobe T; Nishimura F; Katagiri H; Oka Y; Fukushima T; Takahashi SI; Kurihara H; Uchida T; Asano T
    J Biol Chem; 2010 Oct; 285(43):33018-33027. PubMed ID: 20675384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
    Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
    Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.
    Batra S; Sahu RP; Kandala PK; Srivastava SK
    Mol Cancer Ther; 2010 Jun; 9(6):1596-608. PubMed ID: 20484017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
    Bai L; Kao JY; Law DJ; Merchant JL
    Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of peptidyl-prolyl isomerase Pin1 attenuates hepatocytes apoptosis and secondary necrosis following carbon tetrachloride-induced acute liver injury in mice.
    Risal P; Park BH; Cho BH; Kim JC; Jeong YJ
    Pathol Int; 2012 Jan; 62(1):8-15. PubMed ID: 22192799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
    Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
    Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Clarke C; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
    J Hepatol; 2009 Aug; 51(2):296-306. PubMed ID: 19515451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma.
    Shinoda K; Kuboki S; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
    Br J Cancer; 2015 Nov; 113(9):1323-31. PubMed ID: 26461058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.